NO151825C - Mellomprodukt for fremstilling av terapeutisk aktive 5-sulfamoyl-benzosyrederivater - Google Patents

Mellomprodukt for fremstilling av terapeutisk aktive 5-sulfamoyl-benzosyrederivater

Info

Publication number
NO151825C
NO151825C NO784198A NO784198A NO151825C NO 151825 C NO151825 C NO 151825C NO 784198 A NO784198 A NO 784198A NO 784198 A NO784198 A NO 784198A NO 151825 C NO151825 C NO 151825C
Authority
NO
Norway
Prior art keywords
sulfamoyl
preparation
acid derivatives
therapeutic active
benzo acid
Prior art date
Application number
NO784198A
Other languages
English (en)
Other versions
NO151825B (no
NO784198L (no
Inventor
Dieter Borman
Wulf Merkel
Roman Muschaweck
Dieter Mania
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2419970A external-priority patent/DE2419970C3/de
Publication of NO784198L publication Critical patent/NO784198L/no
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO151825B publication Critical patent/NO151825B/no
Publication of NO151825C publication Critical patent/NO151825C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4021-aryl substituted, e.g. piretanide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO784198A 1974-04-25 1978-12-13 Mellomprodukt for fremstilling av terapeutisk aktive 5-sulfamoyl-benzosyrederivater NO151825C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2419970A DE2419970C3 (de) 1974-04-25 1974-04-25 3-<l-Pyrrolidinyl)-4-phenoxy-5sulfamoylbenzoesäure und Verfahren zu ihrer Herstellung
DE2461601A DE2461601C2 (de) 1974-04-25 1974-12-27 3-Pyrrolidino-4-phenoxy-5-sulfamoylbenzoesäureester und Verfahren zu ihrer Herstellung

Publications (3)

Publication Number Publication Date
NO784198L NO784198L (no) 1975-10-28
NO151825B NO151825B (no) 1985-03-04
NO151825C true NO151825C (no) 1985-06-12

Family

ID=25767039

Family Applications (5)

Application Number Title Priority Date Filing Date
NO751470A NO146745C (no) 1974-04-25 1975-04-24 Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklisk substituerte 5-sulfamoylbenzoesyrederivater
NO784196A NO149736C (no) 1974-04-25 1978-12-13 Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocyklisk substituerte 5-sulfamoylbensosyrederivater
NO784198A NO151825C (no) 1974-04-25 1978-12-13 Mellomprodukt for fremstilling av terapeutisk aktive 5-sulfamoyl-benzosyrederivater
NO784197A NO150681C (no) 1974-04-25 1978-12-13 Mellomprodukter for fremstilling av heterocykliske substituerte 5-sulfamoylbenzosyrederivater
NO833116A NO152749C (no) 1974-04-25 1983-08-30 Substituerte benzosyrederivater som mellomprodukter for diuretika.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO751470A NO146745C (no) 1974-04-25 1975-04-24 Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklisk substituerte 5-sulfamoylbenzoesyrederivater
NO784196A NO149736C (no) 1974-04-25 1978-12-13 Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocyklisk substituerte 5-sulfamoylbensosyrederivater

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO784197A NO150681C (no) 1974-04-25 1978-12-13 Mellomprodukter for fremstilling av heterocykliske substituerte 5-sulfamoylbenzosyrederivater
NO833116A NO152749C (no) 1974-04-25 1983-08-30 Substituerte benzosyrederivater som mellomprodukter for diuretika.

Country Status (22)

Country Link
AR (7) AR215839A1 (no)
AU (1) AU507614B2 (no)
BR (1) BR7502487A (no)
CS (1) CS188242B2 (no)
DD (2) DD124230A5 (no)
DK (1) DK158978C (no)
EG (1) EG11682A (no)
ES (1) ES453840A1 (no)
FI (1) FI62075C (no)
HK (1) HK51279A (no)
HU (1) HU174751B (no)
IE (1) IE42601B1 (no)
IL (2) IL47128A (no)
IT (1) IT1041753B (no)
KE (1) KE2971A (no)
MT (1) MTP779B (no)
MY (1) MY8000060A (no)
NO (5) NO146745C (no)
NZ (1) NZ177095A (no)
RO (6) RO66590A (no)
SE (2) SE404796B (no)
ZM (1) ZM4875A1 (no)

Also Published As

Publication number Publication date
EG11682A (en) 1978-03-29
KE2971A (en) 1979-07-06
RO70353A (ro) 1981-08-17
SE435379B (sv) 1984-09-24
AU507614B2 (en) 1980-02-21
RO70426A (ro) 1980-12-30
ES453840A1 (es) 1978-01-16
IT1041753B (it) 1980-01-10
SE7712097L (sv) 1977-10-27
AR217055A1 (es) 1980-02-29
NO146745C (no) 1982-12-01
AU8047475A (en) 1976-10-28
BR7502487A (pt) 1976-03-09
IL56919A0 (en) 1979-05-31
FI751213A (no) 1975-10-26
DD124230A5 (no) 1977-02-09
SE404796B (sv) 1978-10-30
NZ177095A (en) 1979-03-16
RO66590A (ro) 1980-07-15
NO149736C (no) 1984-06-20
NO784197L (no) 1975-10-28
NO833116L (no) 1975-10-28
NO751470L (no) 1975-10-28
AR231135A1 (es) 1984-09-28
MTP779B (en) 1976-08-31
NO152749C (no) 1985-11-13
DD119589A5 (no) 1976-05-05
AR216633A1 (es) 1980-01-15
NO150681C (no) 1984-11-28
NO150681B (no) 1984-08-20
NO152749B (no) 1985-08-05
NO146745B (no) 1982-08-23
IL47128A (en) 1984-02-29
DK158978B (da) 1990-08-13
MY8000060A (en) 1980-12-31
AR217056A1 (es) 1980-02-29
AR219057A1 (es) 1980-07-31
DK179875A (da) 1975-10-26
RO70678A (ro) 1982-09-09
FI62075B (fi) 1982-07-30
AR215839A1 (es) 1979-11-15
DK158978C (da) 1991-01-07
RO81781A (ro) 1983-06-01
NO784196L (no) 1975-10-28
HK51279A (en) 1979-08-03
AR218225A1 (es) 1980-05-30
ZM4875A1 (en) 1975-12-22
RO81781B (ro) 1983-05-30
RO70346A (ro) 1982-08-17
IE42601L (en) 1975-10-25
SE7504841L (sv) 1975-10-27
NO151825B (no) 1985-03-04
FI62075C (fi) 1982-11-10
IL47128A0 (en) 1975-07-28
IE42601B1 (en) 1980-09-10
CS188242B2 (en) 1979-02-28
NO149736B (no) 1984-03-05
HU174751B (hu) 1980-03-28
NO784198L (no) 1975-10-28

Similar Documents

Publication Publication Date Title
NO145382C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater.
NO146200C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 16-oksygenerte prostansyrederivater
NO784397L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater
NO145247C (no) Fremgangsmaate for fremstilling av clavulansyre
NO141013C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive bifenylyl-derivater
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
NO146865C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO140978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO146198C (no) Mellomprodukt for fremstilling av 5-fluor-2-methyl-1-(p-methylsulfinylbenzyliden)-ind-2-en-3-yl-eddiksyre
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO143499C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO145383C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.
NO146672C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater
SE414029B (sv) Forfarande for framstellning av terapeutiskt aktiva fentiazinderivat
NO139733C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive derivater av metylamin
SE407687B (sv) Forfarande for framstellnig av farmaceutiskt aktiva leurosinderivat
NO146138C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoesyrederivater
NO146136C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater
NO145074C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzazepinderivater
SE7610968L (sv) Forfarande for framstellning av biologiskt aktiva di-karboxylsyraderivat
SE7607026L (sv) Forfarande for framstellning av 5-alkylpikolinsyra